High-dose irradiation for prostate cancer via a high-dose-rate brachytherapy boost: Results of a phase I to II study

Conclusion: There is a strong dose-response relationship for intermediate- to high-risk prostate cancer patients. Improved locoregional control with higher radiation doses alone can significantly decrease biochemical and clinical failures.